ES2898344T3 - Ribonucleósidos de piridopirrolopirimidina sustituidos para usos terapéuticos - Google Patents

Ribonucleósidos de piridopirrolopirimidina sustituidos para usos terapéuticos

Info

Publication number
ES2898344T3
ES2898344T3 ES19710587T ES19710587T ES2898344T3 ES 2898344 T3 ES2898344 T3 ES 2898344T3 ES 19710587 T ES19710587 T ES 19710587T ES 19710587 T ES19710587 T ES 19710587T ES 2898344 T3 ES2898344 T3 ES 2898344T3
Authority
ES
Spain
Prior art keywords
amino
alkyl
sulfanyl
dmso
ddd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19710587T
Other languages
English (en)
Spanish (es)
Inventor
Lucia Veselovska
Michal Hocek
Marian Hajduch
Petr Dzubak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Organic Chemistry and Biochemistry CAS
Palacky University Olomouc
Original Assignee
Institute of Organic Chemistry and Biochemistry CAS
Palacky University Olomouc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Organic Chemistry and Biochemistry CAS, Palacky University Olomouc filed Critical Institute of Organic Chemistry and Biochemistry CAS
Application granted granted Critical
Publication of ES2898344T3 publication Critical patent/ES2898344T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES19710587T 2018-03-12 2019-03-04 Ribonucleósidos de piridopirrolopirimidina sustituidos para usos terapéuticos Active ES2898344T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2018-121A CZ308104B6 (cs) 2018-03-12 2018-03-12 Pyridinopyrrolopyrimidinové ribonukleosidy pro terapeutické použití
PCT/CZ2019/050008 WO2019174657A1 (fr) 2018-03-12 2019-03-04 Ribonucléosides de pyridopyrrolopyrimidine substitués à usage thérapeutique

Publications (1)

Publication Number Publication Date
ES2898344T3 true ES2898344T3 (es) 2022-03-07

Family

ID=65763222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19710587T Active ES2898344T3 (es) 2018-03-12 2019-03-04 Ribonucleósidos de piridopirrolopirimidina sustituidos para usos terapéuticos

Country Status (9)

Country Link
US (1) US11299510B2 (fr)
EP (1) EP3765475B1 (fr)
JP (1) JP6973761B2 (fr)
AU (1) AU2019235042B2 (fr)
CA (1) CA3090343C (fr)
CZ (1) CZ308104B6 (fr)
ES (1) ES2898344T3 (fr)
PL (1) PL3765475T3 (fr)
WO (1) WO2019174657A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024166131A1 (fr) * 2023-02-09 2024-08-15 Satyarx Pharma Innovations Private Limited Composés hétéroaryle en tant qu'inhibiteurs de pkmyt1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003272175A1 (en) * 2002-10-21 2004-05-04 Aprea Ab Reactivation of wild type p53 in human tumour cells by a low molecular weight compound
US20050203063A1 (en) * 2003-09-12 2005-09-15 Raymond Deshaies Proteasome pathway inhibitors and related methods
EP1830183A1 (fr) * 2004-12-21 2007-09-05 Kyoto University Sonde, dispositif d'identification de region nucleotidique et procede d'identification de region nucleotidique
WO2009089804A1 (fr) 2008-01-18 2009-07-23 Institute Of Organic Chemistry And Biochemistry As Cr, V.V.I. Nouveaux nucléosides 7-déazapurine cytostatiques
CA2966647A1 (fr) 2009-04-22 2010-10-28 Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. Nouveaux nucleosides 7-deazapurine a des fins therapeutiques
CA3029170C (fr) * 2016-06-29 2021-02-16 Ustav Organicke Chemie A Biochemie Av Cr, V.V.I. Ribonucleosides de thienopyrrolopyrimidine substitues a usage therapeutique
CN113813231B (zh) 2016-07-01 2022-06-21 四川大学 抗菌肽衍生物在制备核酸载体中的用途及核酸载体
CZ307334B6 (cs) * 2016-08-02 2018-06-13 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. Substituované heteropentadieno-pyrrolopyrimidinové ribonukleosidy pro terapeutické použití

Also Published As

Publication number Publication date
US11299510B2 (en) 2022-04-12
CZ2018121A3 (cs) 2019-09-25
WO2019174657A1 (fr) 2019-09-19
CZ308104B6 (cs) 2020-01-08
AU2019235042B2 (en) 2021-03-04
PL3765475T3 (pl) 2022-01-31
US20210002321A1 (en) 2021-01-07
EP3765475B1 (fr) 2021-09-15
CA3090343A1 (fr) 2019-09-19
JP2021516687A (ja) 2021-07-08
JP6973761B2 (ja) 2021-12-01
EP3765475A1 (fr) 2021-01-20
AU2019235042A1 (en) 2020-09-10
CA3090343C (fr) 2022-10-04

Similar Documents

Publication Publication Date Title
CN103534254B (zh) 作为抗肿瘤剂的三环和四环吡唑并[3,4-b]吡啶化合物
KR100226114B1 (ko) 항증식 작용을 가진 퀴나졸린 화합물
ES2432361T3 (es) Derivados de pirrolotriazina útiles para el tratamiento de cáncer por inhibición de cinasa Aurora
JP5778145B2 (ja) 抗癌剤としてのベンゾキノリジニウム塩誘導体
KR100193593B1 (ko) 6,9-비스 (치환된 아미노) 벤조 [g]이소퀴놀린 -5,10- 디논 및 이를 포함하는 약제학적 조성물
US9481678B2 (en) Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptors
ES2898344T3 (es) Ribonucleósidos de piridopirrolopirimidina sustituidos para usos terapéuticos
PT1746097E (pt) Heterociclos fundidos de 1,4-di-hidropiridina, processo para a sua preparação, utilização e composições que os contêm
WO1993013079A1 (fr) Quinazolines anti-folates
US10730905B2 (en) Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
US10414788B2 (en) Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use
RU2631100C1 (ru) Новые производные гетероаренантрацен-2-карбоксамидов, ингибирующие опухолевый рост
JP7839786B2 (ja) 新規アミノピリジン及びその癌治療への使用
WO2024240726A1 (fr) Composés imidazo[4,5-c]pyridine pour le traitement du cancer
CN110229157A (zh) 嘧啶并五元芳香杂环类化合物、其制备方法及用途
KR100889839B1 (ko) 신규 2-치환아미노알킬레닐옥시-3-치환페닐에티닐 퀴녹살린유도체
OA19533A (en) Substituted bicyclic heterocyclic compounds as PRMT5 inhibitors.
WO2019170063A1 (fr) Composés d'indolizine, leur procédé de préparation et leur utilisation
WO2016013947A1 (fr) Nouveaux analogues de 1,2,4-triazoles et procédé de préparation d'analogues de 1,2,4-triazoles